Objective: To conduct a systematic review and meta-analysis of the impact of commercial computerized provider order entry (CPOE) and clinical decision support systems (CDSSs) on medication errors, length of stay (LOS), and mortality in intensive care units (ICUs). Methods: We searched for English-language literature published between January 2000 and January 2016 using Medline, Embase, and CINAHL. Titles and abstracts of 586 unique citations were screened. Studies were included if they: (1) reported results for an ICU population; (2) evaluated the impact of CPOE or the addition of CDSSs to an existing CPOE system; (3) reported quantitative data on medication errors, ICU LOS, hospital LOS, ICU mortality, and/or hospital mortality; and (4) used a randomized controlled trial or quasi-experimental study design.
INTRODUCTION
The high rate of medication errors in hospitals is a well-recognized and significant patient safety issue. 1 Medication errors have consistently been attributed to longer hospital stays, increased costs, significant morbidity, and even death. [1] [2] [3] [4] In complex hospital wards, such as intensive care units (ICUs), the prevalence of errors and adverse patient outcomes is higher and of greater severity than in general wards. 5 A clinical review of medical errors in critical care
undertaken by Moyen et al. 6 associated this increased prevalence of errors to risk factors related to the severity of illness of ICU patients, number and type of medications used (i.e., frequent use of boluses and infusions, which often require weight-based dose calculations), and complexity of the ICU environment.
Interventions aimed at preventing medication errors in hospitals, particularly at the prescribing stage, include computerized provider order entry (CPOE) and clinical decision support systems (CDSSs). Systematic reviews of the impact of CPOE and CDSSs across inpatient settings have reported significant reductions in medication errors, [7] [8] [9] [10] [11] while changes in mortality 10, 12 and length of stay (LOS) 11, 12 have not been significant. However, these reviews combined results from homegrown and commercial CPOE systems. Homegrown systems are more likely to demonstrate positive effects on safety and quality of care, as they are under the local control of the implementing institution and have been highly customized for local conditions. 9, 13 As homegrown systems become increasingly difficult for organizations to maintain, almost all future system implementations are likely to involve commercial systems. 13 The lack of specific reviews to guide the large investments being made in sophisticated commercial systems highlights the need to collate and examine research that evaluates the impact of commercial CPOE systems on errors and patient outcomes, 7, 8 particularly among populations most at risk of errors and adverse outcomes, such as patients in ICUs. Thus, our aim was to conduct a systematic review and meta-analysis of evidence of the impact of commercial CPOE and CDSSs on medication errors, LOS, and mortality in ICUs.
METHOD

Search strategy
We searched for English-language literature published between January 2000 and January 2016 using Medline and Embase via Ovid, and The Cumulative Index to Nursing and Allied Health Literature (CINAHL) via EBSCOhost. We restricted the date range, as studies conducted prior to 2000 tended to evaluate homegrown CPOE. 7 We used a combination of MeSH terms and keywords related to the intervention (CPOE, CDSS), outcomes of interest (medication errors, LOS, mortality), and study setting (ICU). The complete database search strategy is provided in Appendix A (available as a Supplementary File). We also searched 2 specialized bibliographies-the Inventory of Health Information Evaluation Studies (https://evaldb.umit.at/) and the Health IT Bibliography (https://healthit.ahrq.gov/health-it-tools-and-resources/ health-it-bibliography)-and hand searched the reference lists of all full-text articles that we assessed for potential inclusion. The protocol for this review was guided by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement 14 and was registered with PROSPERO (registration number CRD42013004543).
Study selection
The above search strategy was executed on 17 February 2016 and resulted in the identification of 887 citations. After removing duplicates, the titles and abstracts of 586 unique citations were screened for eligibility. Screening of titles and abstracts was conducted independently by 2 researchers and compared for consistency. Where there was a discrepancy between researchers, the citation was assigned to full-text review. Two researchers also independently reviewed the full text of 124 studies. The authors of 13 studies were contacted in order to obtain clarification or additional data. Three researchers assessed the full text of a subset of 34 studies, which were discussed in depth against the eligibility criteria to determine the final set of included studies. Figure 1 shows the study selection process. We defined CPOE as computer-based systems used for entering orders, including laboratory tests, imaging, nutrition, blood products, and medication prescriptions. Almost all CPOE systems have some level of decision support to assist ordering decisions; however, the degree of sophistication of CDSSs can vary from basic duplicate order alerts to complex algorithms based on patient-specific data. 15 Where studies evaluated the addition of a specific CDSS to an existing CPOE system, such as algorithms developed in response to identified medical errors or quality improvement initiatives, we defined these as "targeted" CDSSs. 16 For studies reporting medication errors, we focused on errors occurring at the prescribing stage, which can include incomplete, incorrect, or inappropriate drug orders. Studies were eligible for inclusion if they: (1) reported results for an ICU population; (2) evaluated the impact of moving from paperbased ordering to CPOE or evaluated the addition of a targeted CDSS to an existing CPOE system; (3) reported quantitative data on ArƟcles added via hand-searching and reference list checking n = 3 ArƟcles included n = 20 medication errors, LOS, or mortality pre-and post-CPOE or CDSS; and (4) used a randomized controlled trial or quasi-experimental study design. Studies were excluded if the CPOE system was not a commercial system, was implemented prior to the year 2000, or was implemented alongside other interventions making it difficult to assess the impact of CPOE (e.g., Abstoss et al. 17 ). For studies assessing the addition of a CDSS to an existing CPOE system, if the CDSS was not integrated with the CPOE system (e.g., Sintchenko et al. 18 ), the study was excluded. We also excluded studies where outcomes were voluntarily reported (e.g., nurses reporting errors in incident reporting systems); studies that were conducted in a simulated environment; qualitative studies or opinion pieces; and studies that were available only as abstracts or posters, as they provided insufficient information to systematically determine eligibility.
Data extraction
We extracted the following data variables into a spreadsheet: study author(s), year of publication, country in which the study was conducted, type of ICU (adult/pediatric), study design, number and type of patients included in the study (all ICU patients/only patients with a specific condition), description of the system implemented (CPOE/ CDSS), and duration of baseline and intervention periods. For studies that reported mortality, we extracted the number of patient deaths in ICU (ICU mortality) and/or the number of ICU patient deaths in hospital (hospital mortality) at baseline and intervention. For studies that measured LOS, we extracted the mean patient LOS in ICU (ICU LOS) and/or the mean LOS of ICU patients in hospital (hospital LOS) at baseline and intervention. For studies that reported medication errors, we extracted the number of prescriptions, prescribing error definitions, total number of prescribing errors at baseline and intervention, and evidence of any new types of errors introduced by the CPOE system.
Quality assessment
We assessed the methodological quality of the included studies using the Effective Public Health Practice Project (EPHPP) quality assessment tool for quantitative studies. 19 The tool was selected because it can be used to assess the methodological quality of both randomized and nonrandomized studies, and has been judged suitable for use in systematic reviews. 20 Using the tool, studies are attributed a rating of strong, moderate, or weak based on 6 components: (1) selection bias, (2) study design, (3) confounders, (4) blinding, (5) data collection methods, and (6) withdrawal and dropouts.
Statistical analysis
We categorized the included studies into those that evaluated the impact of moving from paper-based ordering to CPOE and those that evaluated the impact of adding a targeted CDSS to an existing CPOE system. We then grouped the studies by outcome measure (medication errors, ICU LOS, hospital LOS, ICU mortality, or hospital mortality). Three studies [21] [22] [23] reported ICU LOS using median and interquartile ranges. We contacted the authors of these studies and requested mean and standard deviation (SD) data. We received the results for 1 study; 23 however, the authors for the other 2 studies were no longer in possession of the raw data, so these studies could not be included in meta-analysis for this outcome measure. Mean and SD were estimated 24 for 1 study 25 that reported ICU LOS using median and range. One study 26 reported results on ICU LOS, ICU mortality, and hospital mortality from 4 overlapping study periods.
The results from the longest study periods (i.e., 24-month baseline and 12-month intervention periods) were used for the metaanalyses, while results from the other study periods were used for sensitivity analysis. Three studies [27] [28] [29] reported results from 2 separate intervention periods (e.g., two 2-week periods). We combined the data from the 2 periods into 1 intervention period (e.g., one 4-week period). A study by Kadmon et al. 30 on the impact of CPOE on medication errors included 2 interventions: post-CPOE and post-CPOE with CDSS. We included the results from the latter in the meta-analysis and conducted sensitivity analysis for the results from the post-CPOE-only intervention period. The included studies contained sufficient information to conduct meta-analyses for 4 outcome measures: medication errors, ICU LOS, ICU mortality, and hospital mortality. We calculated relative risks (RRs) for medication errors, ICU mortality, and hospital mortality, and mean difference for ICU LOS. A meta-analysis for each outcome measure was performed using random effects models to pool the results and, in order to be conservative, the Knapp-Hartung approach 31 was applied to account for heterogeneity between studies. The meta-analyses results are presented using forest plots (Figures 2-5). Between-study heterogeneity was evaluated using chi-square tests and I 2 statistics. 32 The potential for publication bias for each meta-analysis was assessed by inspection of funnel plots and statistical tests based on weighted linear regression of the intervention effect on its standard error. 33 Subgroup meta-analyses were also conducted by study quality and ICU type (adult/pediatric) when appropriate. Studies conducted in neonatal ICUs [34] [35] [36] were categorized as pediatric. Sensitivity analyses were conducted using different measurements for the outcomes, such as odds ratios and standardized mean differences. All statistical tests were 2-sided and were evaluated at a significance level of 0.05. Analyses were carried out using R version 3.2.1.
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RESULTS
Study characteristics
Twenty studies met our inclusion criteria: 16 that assessed the transition from paper-based ordering to CPOE 23,25-30,34-36,38-43 and 4 that examined the addition of a targeted CDSS to an existing CPOE system 21, 22, 44, 45 (Table 1) . Eleven studies were conducted in the 
Studies comparing CPOE to paper
The 16 studies that assessed the transition from paper-based ordering to CPOE contained sufficient information to perform meta-analysis for 4 outcomes: medication errors, ICU LOS, ICU mortality, and hospital mortality. A summary of the findings of these 16 studies is provided in Appendix B (available as a Supplemen tary File).
Medication errors
Of the 10 studies examining the impact of CPOE on medication errors, 9 23, [27] [28] [29] [30] 35, 38, 41, 42 were included in the meta-analysis. The broad definition of medication prescribing errors was similar across the studies and included illegible, erroneous, or omitted information (Appendix C, available as a Supplementary File). However, the level of detail regarding the specific elements that were included varied between the studies. Some studies, for example, indicated that missing weight 41 or no signature 29, 42 constituted an error of omission and some included rule violations, 30, 41 while other studies did not list these elements in their error definitions. There were also different methods used to determine error rates. Subsequently, there was significant variation in the frequency of errors, with pre-CPOE error rates ranging between 4.5% 38 and 58.2%, 35 and post-CPOE error rates ranging between 0% 27 and 8.2%. 29 There was evidence of heterogeneity between studies (I 2 ¼ 99.65%, P < .0001). Seven of the studies reported a significant reduction in medication errors following CPOE implementation, 1 study 30 reported no change, and 1 study 38 reported a significant increase in errors. Overall, there was evidence that the introduction of CPOE was associated with a significant reduction in the medication error rate by 85% (pooled RR: 0.15, 95% confidence interval (CI), 0.03-0.80, P ¼ .03) (Figure 2 ). There was no evidence of publication bias (P ¼ .07). Sensitivity analysis using results from the post-CPOE-only period (instead of the post-CPOE and CDSS period) in the Kadmon et al. study 30 34 provided data on medication errors that was not included for synthesis via meta-analysis. The study looked at errors within a subgroup of ICU patients (very low birth weight neonates receiving gentamycin on admission), while the studies included in the meta-analysis looked at all ICU patients during their respective study periods. Cordero et al.'s 34 study found 14 errors in 105 orders examined in the baseline period. In the intervention period, no errors were found among the 89 orders examined. Of the types of errors reported across the studies, elimination of illegible orders was the most frequently reported benefit following CPOE implementation. 28, 29, 35, 41 Three studies reported new error types arising due to CPOE. Armada et al. 28 and Colpaert et al. 23 identified problems with duplicate prescriptions, while Armada et al. 28 and Shulman et al. 42 both found problems with erroneous selection from dropdown menus, with Shulman et al. 42 indicating that selection of wrong dose from a dropdown menu resulted in 1 potentially fatal intercepted error. However, Shulman et al. 42 also found that the frequency of errors considered moderate/major decreased 23 similarly reported a decrease in serious medication prescribing errors, from 4.9% to 1.8% of audited orders.
ICU LOS
Seven studies 23, 25, 26, 28, 38, 39, 41 were included in the meta-analysis examining the association between CPOE introduction and ICU LOS. There was evidence of heterogeneity between studies (I 2 ¼ 54.42%, P ¼ .02).
Only 1 study reported a significant finding, with ICU LOS found to decrease from a mean of 7.44 days to 5.96 days following CPOE implementation. 23 Overall, there was no evidence of change in ICU LOS following the introduction of CPOE (pooled mean difference: À0.10, 95% CI, À0.81-0.60, P ¼ .7; Figure 3 ). There was no evidence of publication bias (P ¼ .2). Subgroup analysis of the 5 adult ICU studies 23, 25, 26, 28, 38 (pooled mean difference: À0.01, 95% CI, À1.16-1.13, P ¼ .9) and the 4 studies with a quality rating of moderate 26, 28, 39, 41 (pooled mean difference: À0.40, 95% CI, À1.07-0.26, P ¼ .1) showed no evidence of reduction in ICU LOS following CPOE implementation. Two studies 25, 26 reported on hospital LOS for ICU patients;
however, the data were insufficient to perform meta-analysis. Neither study reported a significant change in hospital LOS following the implementation of CPOE.
ICU mortality
Six studies 26, 28, 30, 34, 39, 43 were included in the meta-analysis examining the association between CPOE introduction and ICU mortality. The studies were found to be homogenous (heterogeneity between studies:
Overall, there was evidence that the introduction of CPOE reduced ICU mortality by 12% (pooled RR: 0.89, 95% CI, 0.78-0.99, P ¼ 0.04; Figure 4 ). There was no evidence of publication bias (P ¼ .7). Subgroup analysis of the 4 pediatric studies 30, 34, 39, 43 showed no significant change in ICU mortality (pooled RR: 0.84, 95% CI, 0.60-1.19, P ¼ .2), while subgroup analysis of the 5 studies with a quality rating of moderate 26, 28, 34, 39, 43 revealed a 14% reduction in ICU mortality after CPOE implementation (pooled RR: 0.86, 95% CI, 0.78-0.96, P ¼ .02).
Hospital mortality
Four studies 25, 26, 36, 40 were included in the meta-analysis examining the impact of CPOE on hospital mortality for ICU patients. There was evidence of heterogeneity between studies (I 2 ¼ 82.53%, P ¼ .0006). Only 1 study reported a significant finding, with mortality found to increase from 39 deaths in 790 patients to 36 deaths in 312 patients following the introduction of CPOE. 40 Overall, however, there was no significant association between CPOE introduction and hospital mortality (pooled RR: 1.17, 95%CI, 0.53-2.54, P ¼ .6; Figure 5 ). There was no evidence of publication bias (P ¼ .5). Subgroup analysis of the 3 studies with a quality rating of moderate 26, 36, 40 revealed similar results to the overall finding (pooled RR: 1.20, 95%CI, 0.28-5.24, P ¼ .6).
Studies evaluating targeted CDSSs
Four studies examined the addition of a targeted CDSS to an existing CPOE system 21, 22, 44, 45 and reported outcomes on ICU LOS, hospital LOS, ICU mortality, and hospital mortality ( Table 2) . A study that examined the impact of a rule restricting the scheduling of repeat orders (i.e., complete blood cell counts, chemistry, and coagulation studies within a 24-h interval) in a pediatric setting reported a significant decrease in both ICU LOS (from a mean of 5.1 days to 4.2 days) and hospital LOS (from a mean of 16.8 days to 11.6 days). 45 Another study in a pediatric setting also reported a significant decrease in hospital LOS (from a mean of 16.4 days to 11.5 days) following the introduction of a red blood cell transfusion algorithm. 44 The 2 studies conducted in adult ICUs did not find significant changes in ICU LOS 21, 22 or hospital LOS 21 following the addition of a targeted CDSS to an existing CPOE system. Only 1 study reported a significant change in hospital mortality for ICU patients, from a rate of 0.10 deaths per patient to 0.13 deaths per patient, following the addition of a red blood cell transfusion algorithm to an existing CPOE system in an adult ICU. 21 There were no significant findings among the other 3 studies 22, 44, 45 that examined hospital mortality, nor the 2 studies 21, 22 that assessed ICU mortality.
DISCUSSION
The transition from paper-based ordering to commercial CPOE systems in ICUs was found to be associated with an 85% reduction in medication prescribing error rates. This significant decrease in medication errors is consistent with reviews of CPOE implementation in other inpatient settings. [7] [8] [9] [10] [11] Overall meta-analysis of LOS and hospital mortality outcomes did not demonstrate a significant change following commercial CPOE implementation in ICU, which is also in line with other inpatient settings. 10, 12 However, analysis of ICU mortality showed CPOE implementation to be associated with a 12% mortality risk reduction in ICUs. In 2005, Han et al. 40 reported the findings from a study that included 1102 pediatric patients admitted via interfacility transport directly to ICU: 790 patients during a 13-month baseline period and 312 patients during a 5-month post-CPOE implementation period. The findings revealed a significant increase in mortality among the cohort of patients following implementation of a commercial CPOE system; from 39 at baseline to 36 post-CPOE (P < .001). 40 While such findings are cause for concern, subsequent studies of critically ill patients, both in pediatric 30, 36, 39 and adult 26, 28 ICUs, have not demonstrated any significant change in mortality following CPOE implementation. However, a consistent issue across all of these studies, including Han et al., 40 is small sample sizes that may not be powered to detect a true effect. 46 Conversely, a 2010 study of a commercial CPOE by Longhurst et al. 43 implemented at a pediatric hospital found a significant decrease in mortality. The study included a substantial sample of 80 063 patient discharges spanning a 6-year baseline period and 17 432 patient discharges during the 18-month post-CPOE implementation period. They found that the mean monthly adjusted hospitalwide mortality rate decreased by 20%. Within the current review, the individual studies that assessed ICU mortality did not demonstrate an effect. Increasing the statistical power through meta-analysis found a positive effect (even with the use of a conservative approach) of ICU mortality reduction in critically ill populations following CPOE implementation. These findings highlight the importance of future studies that include larger sample sizes that are sufficiently powered to accurately and reliably detect clinically relevant rates of change in important indicators following CPOE system introduction. Han et al.'s 40 study also served to demonstrate the need to monitor outcomes following system implementation, particularly as it is now well recognized that system implementations can result in unanticipated work process changes and unintended consequences. [47] [48] [49] Han et al., for example, suggested that the negative outcomes they identified were affected by a combination of order delays due to the inability to "pre-register" patients into the system, the increased time required to enter orders at computer terminals located away from the patient bedside, the reduction of staff interaction, and delays in medication administration due to the relocation of drugs from the ward to a centralized pharmacy service. Another unintended consequence of CPOE implementation can be the emergence of new system-related errors. 50, 51 Among the 10 studies included in this review that examined medication errors, only a few assessed the errors that occurred following the implementation of CPOE and identified duplicate prescriptions and erroneous selection from dropdown menus as new system-related errors. These few studies also found that the severity of errors changed, with the frequency of serious errors decreasing by > 50%. The limited evidence base of the types of errors and potential new risks occurring in critical care settings post-CPOE implementation underscores the importance of future research that not only quantifies the changes in error rates and patient outcomes but endeavors to understand the nature of these changes. Such information is critical to ongoing improvement in the design of CPOE systems and the delivery of safe patient care. While we identified a significant overall reduction in medicationprescribing error rates following CPOE implementation, we also found that the frequency of medication errors found in each independent study varied substantially. This was particularly evident in baseline error rates, which ranged between 4.5% and 58.2%, whereas post-CPOE error rates ranged between 0% and 8.2%. Inherent differences between study settings may account for some of this variation. However, differences among definitions as to what constitutes a medication prescription error, as well the methods used to detect errors, are the likely cause of the majority of disparity between studies. 6, 52 Some studies, for example, indicated that missing weight or no signature constituted an error of omission and some included rule violations, while other studies did not list these elements in their error definitions. These findings reiterate previous calls for the need to use a more standardized set of criteria when defining and reporting medication errors. Reckmann et al., 52 for example, suggest that future studies should include a clear definition of prescribing errors; absolute error rates pre-and post-CPOE; appropriate denominators, such as total number of orders; proportions of errors categorized according to a standardized severity scale; and appropriate significance testing. Such information would facilitate more accurate comparison between studies. The significant reduction in medication error rates following CPOE implementation is not surprising. The automation and standardization of the format and structure of electronic orders intrinsically eliminates some error types, such as legibility errors. While eliminating these types of errors is important, the greater challenge is enabling appropriate, evidence-based care. It is here that the implementation of comprehensive CPOE applications that include sophisticated CDSSs are anticipated to have the greatest impact on errors and adverse outcomes. 7 However, there is currently very limited evidence on the impact of adding targeted CDSSs into existing commercial CPOE systems in ICUs. Among the 4 studies we identified, the study findings of patient outcomes proved to be mixed. While studies found that the implementation of CDSSs enhanced the adoption of evidence-based recommendations, this positive impact on the process of care in ICUs did not necessarily translate into improved patient outcomes. Adams et al. 44 and Pageler et al. 45 reported significant decreases in LOS following the addition of CDSSs, while other studies found no change. With regard to mortality, Fernandez Perez et al. 21 reported an increase in unadjusted hospital mortality, but no change in ICU mortality, while the other studies found no change in mortality following the addition of CDSSs. This suggests the need for more sophisticated multilevel statistical approaches in a much needed area of research, as examinations of mortality and LOS need to account for many complex variables, including acuity and patient demographics.
Limitations
An inherent limitation of systematic reviews is that the soundness of the review findings is reliant on the quality of the included studies.
We rated the quality of the studies included in this review as either methodologically strong, moderate, or weak based on the EPHPP quality assessment tool criteria. 19 While we found the majority of studies to be of moderate quality (13 of 20 studies), there were no studies rated as strong. As such, in addition to evaluating the findings from the current evidence base, our study also highlights key areas where there is a need for more robust studies with larger sample sizes in order to ascertain the true effect of the implementation of CPOE systems and CDSSs. While previous systematic reviews on the impact of CPOE in other hospital settings have found the evidence to be largely US-based as a result of including homegrown systems, 11 a strength of our review is that we focused on commercial systems. As such, the evidence base we identified was more global, with half of the included studies conducted outside the US, making it more applicable to international settings.
CONCLUSION
Critical care settings, both adult and pediatric, involve unique complexities that make them vulnerable to medication errors and adverse patient outcomes. While limited, the current evidence base suggests that the implementation of commercial CPOE systems can significantly decrease the frequency of medication prescribing error rates, as well as reducing the risk of mortality in ICUs. Future studies that aim to examine medication errors and patient outcomes should ensure they have sufficient sample sizes that are powered to identify the true effect of CPOE implementation. There is also a critical need to understand the nature of errors arising post-CPOE and how the addition of advanced CDSSs can be used to provide even greater benefit to delivering safe and effective patient care.
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